—
C+
C+ The full Closelook — membership. Open the C+ overview

AstraZeneca PLC (AZN) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — AstraZeneca PLC

AZN in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
AstraZeneca discovers, develops, manufactures and sells prescription medicines across several therapy areas, including oncology, cardiovascular and renal disease, respiratory and immune conditions, vaccines and rare diseases. It markets products such as Tagrisso, Imfinzi, Farxiga and Symbicort through distributors and local offices worldwide, reaching primary and specialist doctors. The company has also signed collaborations with Tempus and Pathos, with CSPC Pharmaceutical, and with Nucs AI to apply artificial intelligence to drug discovery and treatment prediction. It is headquartered in Cambridge, England.
Where it sits in the stack
AstraZeneca carries no seat in Closelook's index; it sits within our Healthcare sleeve, under drug manufacturers of general prescription medicines.
Who it is priced against
Closelook's peer group has not been set for this name; the market most often compares it with GSK, another UK-based diversified pharmaceutical maker.
Why Closelook tracks it
AstraZeneca holds no index seat and carries no Closelook score yet. The diary has flagged it five times in the Daily Pulse edition, most often within the Pattern Scanner's support-confluence signals, sitting in yellow or red regimes alongside other defensive and pharma names.
What the diary watches
The diary watches whether AstraZeneca's Pattern Scanner signal moves from a yellow into a green regime, which would mark a shift from a cautious to a firmer setup.

AstraZeneca PLC (AZN) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for AZN, from the same nightly bakes the boards use. Research diary readings, not advice.

The Street on this name 3 analyst actions on the wire · latest: upgrade by Deutsche Bank, 2026-09-15

The Street on this name

Analyst actions and the latest print for AZN from the Closelook wires — third-party opinions on the record, not our readings.

  • Upgrade Deutsche Bank — Sell → Hold Upgraded to Hold from Sell 2026-09-15
  • Initiation RBC Capital — at Outperform Initiated to Outperform 2026-09-08
  • Initiation CICC — at Outperform Initiated to Outperform 2026-08-23

3 actions on the analyst wire since 2026-08-13: 1 upgrade, 2 initiations. Analyst wire → · Earnings wire →

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is AstraZeneca PLC (AZN)?

AstraZeneca PLC trades as AZN on the US exchange (US) in the Closelook research universe, as of the registry build of 2026-09-18.

Is AZN in a Closelook index?

Not currently — AstraZeneca PLC is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

What does AstraZeneca PLC do?

AstraZeneca discovers, develops, manufactures and sells prescription medicines across several therapy areas, including oncology, cardiovascular and renal disease, respiratory and immune conditions, vaccines and rare diseases. It markets products such as Tagrisso, Imfinzi, Farxiga and Symbicort through distributors and local offices worldwide, reaching primary and specialist doctors. The company has also signed collaborations with Tempus and Pathos, with CSPC Pharmaceutical, and with Nucs AI to apply artificial intelligence to drug discovery and treatment prediction. Closelook's peer group has not been set for this name; the market most often compares it with GSK, another UK-based diversified pharmaceutical maker.

Where does AstraZeneca PLC sit in the AI build-out?

AstraZeneca carries no seat in Closelook's index; it sits within our Healthcare sleeve, under drug manufacturers of general prescription medicines. AstraZeneca holds no index seat and carries no Closelook score yet. The diary has flagged it five times in the Daily Pulse edition, most often within the Pattern Scanner's support-confluence signals, sitting in yellow or red regimes alongside other defensive and pharma names.

What has Wall Street done on AstraZeneca PLC recently?

The most recent analyst action on AstraZeneca PLC on the Closelook wire is a upgrade by Deutsche Bank on 2026-09-15 (Sell → Hold). 3 actions on the analyst wire since 2026-08-13: 1 upgrade, 2 initiations. Analyst actions are third-party opinions recorded by the wire, not Closelook readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

Where has Closelook written about AstraZeneca PLC?

AstraZeneca PLC appears in 5 Closelook pieces, most recently Daily Pulse: Friday flips broadly risk-off — Korea −6.1%, Temperature still 57 (2026-05-18); Daily Pulse: Temperature 61 — semis overheating into the catalyst window (2026-05-12); Daily Pulse: Temperature 62 — Euro-AI leads broad multi-week rally (2026-05-07). What Closelook said most recently: Pattern Scanner: 25 active signals, top-5 all support-confluence — PFE 47 (🟡), NOC 38 (🔴), MCD 37 (🔴), AZN 36 (🟡), UL 29 (🔴) — three red, two yellow, zero green. (Daily Pulse, 2026-05-18). The "Mentioned on Closelook" block on this page lists the long reads, the reference entries and the dailies that name it.

What does this page show?

A live price chart with SMA overlays and drawing tools for AZN, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Mentioned on Closelook 5 pieces · newest: Daily Pulse, “Friday flips broadly risk-off — Korea −6.1%, Temperature still 57” (2026-05-18)

Mentioned on Closelook

Where AZN appears in the diary — 5 pieces, newest first. Every link is our own writing.

Dailies